101 related articles for article (PubMed ID: 23383874)
1. Refractory cutaneous angiosarcoma successfully treated with sunitinib.
Lu HJ; Chen PC; Yen CC; Hsiao FC; Tzeng CH; Ma H; Shiau CY; Chao TC
Br J Dermatol; 2013 Jul; 169(1):204-6. PubMed ID: 23383874
[No Abstract] [Full Text] [Related]
2. Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.
Ono S; Tanioka M; Fujisawa A; Tanizaki H; Miyachi Y; Matsumura Y
Arch Dermatol; 2012 Jun; 148(6):683-5. PubMed ID: 22710450
[No Abstract] [Full Text] [Related]
3. Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate.
Penot P; Bouaziz JD; Battistella M; Kerob D; Pagès C; Vilmer C; Basset-Seguin N; Madjessli N; Comte C; Farges C; Bagot M; le Maignan C; Lebbé C
Br J Dermatol; 2013 Apr; 168(4):871-3. PubMed ID: 22963050
[No Abstract] [Full Text] [Related]
4. Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy.
Gebhardt C; Ziegler B; Stadler S; Goerdt S; Utikal J
Br J Dermatol; 2015 Apr; 172(4):1156-8. PubMed ID: 25204400
[No Abstract] [Full Text] [Related]
5. Flare up of symptoms after discontinuation of sunitinib in patient with lung cancer.
Guo W; Liu X; Gao H
Acta Oncol; 2011 Oct; 50(7):1133-5. PubMed ID: 21861595
[No Abstract] [Full Text] [Related]
6. Docetaxel monotherapy for angiosarcoma in an elderly patient.
Nagano T; Tai Y; Higashida Y; Fujiwara N; Oka M; Nishigori C
Arch Dermatol; 2007 Dec; 143(12):1602-3. PubMed ID: 18087027
[No Abstract] [Full Text] [Related]
7. Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.
Takehara Y; Satoh T; Nishizawa A; Saeki K; Nakamura M; Masuzawa M; Kaneda Y; Katayama I; Yokozeki H
Clin Immunol; 2013 Oct; 149(1):1-10. PubMed ID: 23886549
[TBL] [Abstract][Full Text] [Related]
8. Refractory angiosarcoma of the breast with VEGFR2 upregulation successfully treated with sunitinib.
Silva E; Gatalica Z; Vranic S; Basu G; Reddy SK; Voss A
Breast J; 2015; 21(2):205-7. PubMed ID: 25639617
[No Abstract] [Full Text] [Related]
9. Continuous therapy with sunitinib in patients with metastatic renal cell carcinoma.
Kahl C; Hilgendorf I; Freund M; Casper J
Onkologie; 2008 Sep; 31(8-9):485. PubMed ID: 18787358
[No Abstract] [Full Text] [Related]
10. Continuous daily dosing of sunitinib in patients with metastatic renal cell cancer.
Harshman L; Srinivas S
Onkologie; 2008 Sep; 31(8-9):432-3. PubMed ID: 18787349
[No Abstract] [Full Text] [Related]
11. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel.
Nakamura Y; Nakamura Y; Hori E; Furuta J; Kawachi Y; Otsuka F
Br J Dermatol; 2010 Dec; 163(6):1357-8. PubMed ID: 20731655
[No Abstract] [Full Text] [Related]
12. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
Hoshina D; Abe R; Yoshioka N; Saito N; Hata H; Fujita Y; Aoyagi S; Shimizu H
J Dermatol Sci; 2013 May; 70(2):116-22. PubMed ID: 23522954
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
[TBL] [Abstract][Full Text] [Related]
14. Long-term metronomic docetaxel chemotherapy for inoperative angiosarcoma of the scalp.
Sumikawa Y; Inui S; Nishimura Y; Morita E; Kurachi K
J Dermatol; 2011 Apr; 38(4):393-5. PubMed ID: 21352341
[No Abstract] [Full Text] [Related]
15. A case of cutaneous angiosarcoma successfully treated with eribulin.
Iwamoto K; Fujisawa Y; Ishitsuka Y; Maruyama H; Nakamura Y; Okiyama N; Watanabe R; Fujimoto M
Eur J Dermatol; 2018 Jun; 28(3):410-412. PubMed ID: 29619993
[No Abstract] [Full Text] [Related]
16. [Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
Voss A; Seitz CS; Rose C; Bröcker EB; Goebeler M
Hautarzt; 2001 Oct; 52(10):895-8. PubMed ID: 17690822
[TBL] [Abstract][Full Text] [Related]
17. Image Gallery: A case of cutaneous giant angiosarcoma treated successfully with electrochemotherapy.
Guida M; Ruggieri E; Fucci L; Ressa M; D'Aluisio L; Fanelli G; Strippoli S
Br J Dermatol; 2017 Aug; 177(2):e27. PubMed ID: 28833026
[No Abstract] [Full Text] [Related]
18. Sunitinib monotherapy instead of mitotane combination therapy for the treatment of refractory adrenocortical carcinoma.
Zhuang J; Wang D; Wu R; Tu X; Chen Y; Qiu S
Int J Urol; 2015 Nov; 22(11):1079-81. PubMed ID: 26307384
[No Abstract] [Full Text] [Related]
19. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment.
Guillot B; Raison-Peyron N; Acevedo M; Meunier L; Dandurand M; Meynadier J
Eur J Dermatol; 2000 Jun; 10(4):300-2. PubMed ID: 10846259
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial.
Kroiss M; Quinkler M; Johanssen S; van Erp NP; Lankheet N; Pöllinger A; Laubner K; Strasburger CJ; Hahner S; Müller HH; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2012 Oct; 97(10):3495-503. PubMed ID: 22837187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
